A One-Two Punch: New Drug Overfeeds—Then Starves—Cancer Cells
SMRTR summary
A new cancer drug developed by University of Texas biochemists delivers a two-step attack: it first forces cancer cells to burn through their glucose at an accelerated rate, then blocks their ability to use fatty acids as a backup energy source. This chemical approach works similarly to existing cancer treatments but is smaller, easier to make, and can target proteins inside cells, not just on their surface.
SMRTR provides this summary for quick context. The original article belongs to Nautilus.
Read the original article